US › Healthcare

Jupiter Neurosciences, Inc. Common Stock (JUNS)

US · Healthcare · Biotechnology

$3.01+2.73%

Last close · 2026-09-17

Latest quarter · ended 2026-06-30

Revenue

$24,245

Net profit

$-2.3M

EPS

$-5.06

Net margin

-9,380.9%

Key statistics

Market cap

$4.2M

Forward P/E

28.7

P/B

227.66

Book value

$-5.75

EPS (TTM)

$-19.06

52-week high

$137.96

52-week low

$2.88

50-day MA

$8.41

200-day MA

$35.44

Analyst view

Analysts rate Jupiter Neurosciences, Inc. Common Stock a strong buy (1 buy, 0 hold, 0 sell out of 1) with an average price target of $30.00.

Shareholding

Insiders

21.52%

Institutions

2.25%

Largest institutional holders

Fund	Stake
Vestor Capital Partners	1.68%
Vanguard Capital Management, LLC	0.62%
Geode Capital Management, LLC	0.37%
Citadel Advisors Llc	0.18%
Vanguard Fiduciary Trust Co	0.15%
Northern Trust Corp	0.04%
Virtu Financial LLC	0.02%
UBS Group AG	0.01%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Jupiter Neurosciences, Inc. Common Stock — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc Merck & Company Inc UnitedHealth Group Incorporated Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Novo Nordisk A/S Gilead Sciences Inc Abbott Laboratories

Data updated 2026-09-18.